The antimicrobial proteins lactoferrin (Lf) and lysozyme (Ly) are invariably found in nasal secretions. To investigate the cellular sources and the secretory control of these nasal proteins in vivo, 34 adult subjects underwent nasal provocation tests with methacholine (MC), histamine (H), and gustatory stimuli. Nasal lavages were collected and analyzed for total protein (TP), albumin (Alb), Lf, and Ly. MC (25 mg), H (1 mg), and gustatory stimuli (spicy foods) all increased the concentrations of TP, Alb, Lf, and Ly. However, when each protein was assessed as a percentage of TP (i.e., Alb% = Alb/TP; Lf% = Lf/TP; Ly% = Ly/TP), MC and gustatory stimuli, which both induce glandular secretion, selectively augmented Lf% and Ly% without changing Alb%, while H, which primarily increases vascular permeability, increased Alb% without significantly affecting Lf% or Ly%. Gel electrophoresis and immunoblotting analysis of nasal secretions demonstrated both Lf and Ly in cholinergically induced secretions. Furthermore, histochemical analyses of nasal turbinate tissue revealed Lf and Ly colocalization within the serous cells of submucosal glands, providing evidence that both proteins are strictly glandular products within the nasal mucosa. Therefore, both Lf and Ly are produced and secreted from the glands, and their secretion may be pharmacologically regulated in attempts to improve host defenses. 
Introduction
The sources of human nasal secretions have been previously analyzed by measuring the secretion of albumin (Alb),I secretory IgA (sIgA), nonsecretory IgA, and IgG into induced nasal secretions (1, 2) .2 It was demonstrated that sIgA is a protein produced locally in the nasal mucosa, processed exclusively by the submucosal glands (1) . The secretion of sIgA into nasal secretions is regulated by processes that govern glandular secretion (e.g., the cholinergic nervous system), and therefore sIgA can be used as a marker of glandular secretion. In con-1. Abbreviations used in this paper: Alb, albumin; Alb%, albumin percent; H, histamine; Lf, lactoferrin; Lt'D, lactoferrin percent; Ly, lysozyme; Ly%, lysozyme percent; MC, methacholine; sIgA, secretory IgA; TP, total protein. trast, the serum proteins Alb, non-sIgA, and IgG enter nasal secretions through at least two mechanisms: by increased extravasation from blood vessels into interstitial fluid and transport across the respiratory epithelium into the nasal cavity; or by passage across specialized capillary fenestrae, uptake by the submucosal glands, and transport into the glandular lumen, thus entering the nose as a component of glandular secretions (1) . 2 The sources of the constituent proteins in nasal secretions have been determined by analyzing nasal provocation with methacholine (MC) (1) and histamine (H) (2) , or by stimulating glandular hypersecretion with spicy food challenges, producing a syndrome referred to as gustatory rhinitis (3). While we now have a rudimentary understanding of the sources and controls of some of the proteins found in nasal secretions, the origin and function of most of the other proteins found in respiratory secretions (Table I) have not been fully explored. In particular, two antimicrobial proteins, lactofenin (Lf) and lysozyme (Ly), are described in nasal secretions, yet the origin and cellular sources of these two proteins have not been adequately determined. The purpose of this report is to demonstrate that both of these proteins are of glandular origin, and that their secretion into airway secretions can be controlled pharmacologically.
Methods
Subjects 34 adult subjects (11 male, 23 female) between the ages of 19 and 52 yr were studied after informed consent was obtained. Subjects were not studied within 3 wk after recovering from an upper respiratory tract infection, and no subject experienced nasal symptoms at the time of study. No medications were taken within 48 h of nasal challenge. Atopic subjects were defined as having seasonal symptoms of rhinitis and were skin test positive to relevant allergens as determined by prick tests with a battery of inhaled aeroallergens. Atopic subjects (n = 15) were studied outside of their allergy season during asymptomatic periods. Nonatopic subjects (n = 19) had no allergy symptoms and were skin test negative.
Challenge methods
Nasal challenges were performed as previously described (1) . Nasal lavage fluid was collected through 8F rubber catheters. After the nasal cavity was washed with four 4-ml saline prewashes, the challenge protocols formally began.
All nasal challenge solutions were delivered to only one side of the nasal cavity from a hand-held nebulizer bottle. Challenge solutions (0.3 ml each) were diluted in normal saline. Each challenge period (10 min) was followed by a 4-ml saline lavage.
In the first protocol subjects were challenged sequentially with saline and then 25 mg of MC. In the second challenge protocol saline challenge was followed by a challenge with 1 mg of H.
The third protocol was a different type of challenge protocol and consisted of oral food challenges combined with nasal lavages. Each Glutamate dehydrogenase Antiproteases Leucineaminopeptidase Beta-glucuronidase subject slowly consumed a food item, and then the nasal cavity was lavaged with 4 ml of saline after 10 min. Control foods were defined as those foods that historically were not associated with rhinorrhea, and consisted of wheat crackers, pretzels, sweet peppers, or gefilte fish. Positive foods were foods that historically always produced rhinorrhea in this study population, and included hot chili peppers, horseradish, and hot and sour soup.
Assays
Total protein. Protein in nasal lavage samples was measured by the Lowry method (4) using BSA as the standard.
Albumin. Human serum Alb was measured by a competitive ELISA as previously reported (1) . The assay range was between 1 and 100 Mg/ml.
Ly. Ly was measured by a turbidimetric assay based on the enzymatic hydrolysis of bacterial cell walls (5 with beta-mercaptoethanol and SDS (7) . Each sample (1 Al) was applied to 10-15% polyacrylamide gels, which were then electrophoresed and stained for protein with Coomassie blue as described (8) .
Western blot and immunodetection of proteins. Proteins were transferred from the gels to nitrocellulose by unidirectional diffusion blotting as described (9) . In brief, nitrocellulose wetted with distilled water was superimposed on the gel and the PhastSystem separation and control unit was heated to 70°C for 45 min. The method of immunodetection of proteins has been previously described (9 
Indirect immunohistochemistry
Human inferior nasal turbinates (n = 6) were obtained from patients who underwent turbinectomies for nasal obstruction syndromes. The tissue was fixed in 4% paraformaldehyde in pH 7.4 PBS at 40C for 18 h. Paraffin-embedded sections were cleared in xylene and graded alcohols, and washed in water, PBS, and then 1% nonimmune serum in PBS. Tissue sections were incubated in rabbit antisera to human Alb, Ly, or Lf for 20 h at 4VC in a humidified chamber. After washing with PBS one of two second antibody systems was used. Either colloidal gold-labeled goat anti-rabbit IgG (Auroprobe; Janssen Life Sciences Products, Piscataway, NJ) was used with silver enhancement (IntenSE, Janssen Life Sciences Products), or biotinylated goat anti-rabbit IgG was used with avidin-horseradish peroxidase (Vectastain; Vector Laboratories, Inc., Burlingame, CA) and with 3,3'-diaminobenzidine as the chromogen. Some sections were counterstained with Alcian blue, which stains mucous cells.
Statistics
Data are expressed as the mean±SEM. The two-sample Wilcoxon test (a nonparametric version of the t test) was used for statistical comparisons of control samples with challenge samples.
Results
Protein, Alb, and Alb%. 12 subjects were studied in the MC challenge protocol. The dose of MC used (25 mg) was previously established as effective in inducing glandular secretion (1) . As previously reported, saline provocation did not cause any nasal symptoms, while MC reliably stimulated rhinorrhea, a short-lived nasal congestion, and/or a mild facial flushing in all subjects.
Total protein, Alb, and Alb% data are shown in Fig (Fig. 3) . In addition to the significant increases in TP and Alb, the Alb% also increased significantly. This increase in Alb% has previously been attributed to an increase in vascular permeability (2) .
Lf Lf was measured and Lfo calculated in these same nasal ravages. As shown in Fig. 4 To exclude the possibility that tears, which contain high concentrations of Ly (10, 11) , might contaminate the nasal secretions and account for the increased levels seen after challenge the following study was performed. Three additional subjects with ocular disease (uveitis) were given unilateral topical treatments with anticholinergic medications (Cyclogel or methscopalomine) and were then examined for nasal secretory responses to topical MC. All subjects were studied within 30 min of receiving topical anticholinergic treatment. Both sides of the nose were challenged with saline followed by 25 mg of MC, and nasal lavages were collected 10 min after each challenge. Table III demonstrates that no significant differences were observed between TP, Lf, or Ly secretion from either side of the nose, indicating that the anticholinergic treatment, which prevents unilateral lacrimation, had no effect on the increases in nasal secretion Ly seen after MC stimulation. Since anticholinergic eye drops inhibit the active secretion of Lf or Ly from the lacrimal gland, it was concluded that the Lf and Ly in nasal lavages is derived from increased nasal glandular secretion and not from tear contamination.
Gel electrophoresis and Western blots. Gel electrophoresis was performed on both baseline and stimulated nasal secretions to identify the proteins in nasal secretions. In addition to the nasal lavage samples, standards of Alb, IgG, Lf, Ly, and IgA were run simultaneously on the same gels in an attempt to identify specific protein bands. As shown in Fig. 9 ADDED LYSOZYME (pg/ml) Lf is a 78,000 mol wt protein that exhibits both bacteriostatic and bactericidal properties (12, 13) . It irreversibly binds two atoms of iron, and presumably this is the mechanism by which it exerts much of its antimicrobial properties. In addition, Lf also blocks the formation of complement factor C3 convertase, regulates granulocyte production, and regulates the production of macrophage colony-stimulating factor (13) . The significance of these latter properties of Lf remains unclear.
Lf is commonly found in the external secretions of both nonhumans and humans. It was first described in bovine milk in 1966 (14) . In the human Lf has been found in tears, nasal secretions, bronchial mucus, urine, seminal fluid, uterine cervical mucus, hepatic bile, duodenal contents, pancreatic juices, and in the specific granules of neutrophils (15) . In all of the secretions the levels of Lf far exceed the levels of transferrin, suggesting that while transferrin is the major iron-binding protein in the serum, Lf plays the major role in external secretions (14) .
Serum levels of Lf range from 0.18 to 1.0 ,gg/ml (16) (17) (18) , while plasma levels are between 0.02 and 0.2 gg/ml (16) . In contrast to these relatively low blood levels, Lf levels are significantly higher in several external secretions. In tears, Lf levels range between 1 and 3 mg/ml (I12-14, 19-2 1), accounting for -15-30% of the TP (13) . In human milk Lf is found at -1 mg/ml (15) . In bronchial secretions Lf accounts for as much as 11.5% of the TP (22) .
It should be recognized that some of these secretions are obtained from tissues that may be infiltrated with inflammatory cells such as activated neutrophils. Since neutrophils contain up to [6] [7] [8] ;ig Lf/106 cells (5), at least some ofthe measured Lf may be derived from neutrophils. However, neutrophils cannot account for the high Lf levels measured in normal tears, human milk, or the nasal secretions stimulated by nasal provocation in this study, since neutrophils are not present in significant concentrations in these secretions (< 1,000 cells/ml in nasal lavage fluid).
Ly is another antimicrobial protein found in nasal secretions as well as in many other external secretions. It is a much smaller molecule than Lf with a molecular weight of -14,000. It is a bactericidal protein that enzymatically degrades the bacterial cell walls of susceptible bacteria. It is a ubiquitous protein found in humans as well as many other mammalian species. It has even been found in vegetables such as the turnip (23) .
Ly was first reported in nasal secretions by Fleming in 1922 when he discovered that nasal secretions from a patient with catarrh had a remarkable ability to kill common bacterial species like M. lysodeikticus, in addition to several other different strains of bacteria (23 secretions including tears, bronchial mucus, plasma, sebum, and pus (24). It has been histologically identified in the proximal tubules of the kidney, the stomach gastric glands, the small intestinal Brunner's glands, Paneth cells, lacrimal glands, parotid glands and ducts, bronchial glands, submandibular and sublingual salivary glands, and neutrophils and macrophages (24, 25). As with Lf, Ly is a major protein in tears and is found in concentrations between 1 and 3 mg/ml (10, 11, 21) . In the lung it accounts for nearly 5-6% of the total protein (22) . As with Lf, serum levels of Ly are low, with normal levels reported to be 1.0-1.5 udog/ml (26) .
Ly levels in external secretions vary with age and developmental status. In newborn (full-term) babies the Ly levels are approximately at normal adult levels (27) of both proteins in the same serous cell. In salivary glands, however, the distribution of Lf and Ly does not correspond exactly. Only Ly, but not Lf, is found in the intercalated ducts ofthe salivary glands (25) . Similarly, the distribution of Lfand Ly in the mucosa of the middle ear does not exactly correspond to the distribution seen in the nasal mucosa (32) . Thus the distribution, and presumably the secretion, of both proteins appear to be tissue specific.
There is much evidence that supports the concept that the cholinergic nervous system controls secretion of both Lf and Ly. In a tissue culture system explants oflung tissue stimulated with the cholinergic agonist bethanechol increased Ly secretion in parallel with mucous glycoprotein secretion. This increased secretion of Ly was 100% inhibited by pretreatment of the tissue with atropine (34) . In a similar manner cultures of ferret trachea were stimulated with MC, and this resulted in a significant increase in Ly secretion into the culture media. Ferret Ly secretion was prevented with atropine pretreatment. Histological examination of this ferret trachea tissue before and after MC stimulation showed a remarkable post-MC reduction in both serous cell granules and in Ly immunoreactive staining (33) . In a third study reflex-stimulated tears, which invoke a cholinergic efferent pathway, produced a large increase in Ly secretion as compared with baseline levels (35) . All three studies confirm the findings described in the current nasal provocation study, in which cholinergic stimulation selectively increased the secretion ofboth Lfand Ly. In addition, preliminary data from this lab suggest that the cholinergic-induced increases in both Lfand Ly secretion can be inhibited by atropine pretreatment of the nasal mucosa (data not shown).
The secretion of Lf and Ly into induced nasal secretions increased in parallel, with a high degree of significance, after cholinergic stimulation (Table II) . It is apparent, however, that much more Ly is secreted into nasal secretions than Lf(almost 10 times as much). This difference in relative concentration reflects a significant difference between the protein constituents in secretions from the nose and tears. Tears contain approximately the same concentrations of both Lf and Ly (-1-3 mg/ml of each protein). Thus this difference in glandular protein constituents represents the tissue-specific heterogeneity referred to previously. Furthermore, the secretion of Lf and Ly appears to be regulated somewhat differently after nasal stimulation. While both proteins increased in concentration after cholinergic challenge, clearly the secretion of Ly was much more pronounced, the LyO nearly tripled, and there was a much smaller increase in LfU/o. Similarly, H stimulation also produced a somewhat varied response, with the Lfo decreasing below baseline levels while the Ly% was essentially unchanged.
One major conclusion that is supported by this and other studies is that nasal secretions serve more functions than were previously appreciated. In addition to providing lubrication, one can speculate that the submucosal gland's predominant role in the upper airways is to provide a first line ofdefense for the mucosa 
